What Happened?
Brisbane, CA-based Maverick Therapeutics Resigned Chulani Karunatilake as Senior Vice President of Technical Operations
About the Company
Maverick Therapeutics is pioneering the next generation of redirected T-cell targeted immunotherapies. Mavericks highly innovative platform, COBRA™, is the most advanced bispecific T-cell engaging platform in its class, designed to safely target solid tumors with highly specific and potent activity.
About the Person
Chulani Karunatilake is Chief Technology Officer at Werewolf Therapeutics. Previously, Chulani held various senior IT leadership roles in the industry.
Info Source
News
Short Profile